Sort   by:  
 Page size 
MetabolomicsTemporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment
Lung cancer causes more deaths in men and women than any other cancer related disease. Currently, few effective strategies exist to predict how patients will respond to treatment. We evaluated the serum metabolomic profiles of 25 lung cancer patients undergoing chemotherapy ± radiation to evaluate t...
2017-01-19 | MTBLS200 | MetaboLights
UnknownReproducibility of proton density fat fraction assessment of thigh muscle in a multi-site, multi-vendor cohort study at 10 years after anterior cruciate ligament reconstruction.
Not available
S-EPMC11651994 | biostudies-literature
UnknownAnticoagulation does not increase risk of mortality or ICU admission in hospitalized COVID-19 patients with gastrointestinal bleeding: Results from a New York health system.
Not available
S-EPMC7834436 | biostudies-literature
TranscriptomicsDynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer
Tamoxifen is the most widely prescribed anti-estrogen treatment for patients with ER-positive breast cancer. However, there is still a need for biomarkers that reliably predict endocrine sensitivity in breast cancers and these may well be expressed in a dynamic manner. In this study we assessed ge...
ORGANISM(S): Homo sapiens 
2010-06-17 | E-GEOD-22386 | biostudies-arrayexpress
UnknownProgression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).
Not available
S-EPMC6532366 | biostudies-literature
UnknownThe comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
Not available
S-EPMC4917745 | biostudies-literature
ProteomicsA novel small molecule that induces cytotoxicity in lung cancer cells inhibits disulfide reductases GSR and TXNRD1
High-throughput phenotype-based screening of large libraries of novel compounds without known targets can identify small molecules that elicit a desired cellular response, but additional approaches are required to find and characterize their targets and mechanisms of action. Here we show that a comp...
ORGANISM(S): Homo sapiens (Human) 
2022-02-23 | PXD027228 | Pride
Lung cancer Thermal proteome profiling Lcs3-sensitive luad cells 
UnknownNifLA complex from Azotobacter vinelandii
Not available
EMPIAR-12868 | biostudies-other
UnknownCyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.
Not available
S-EPMC6402543 | biostudies-literature
UnknownAbnormal sleep physiology in children with 15q11.2-13.1 duplication (Dup15q) syndrome.
Not available
S-EPMC8336244 | biostudies-literature
Sort   by:  
 Page size